October 2020 FDA Recall Drug by Jarrow Formulas Inc (D-0302-2021 - Mislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.)

This Class II drug recall was voluntarily initiated by Jarrow Formulas Inc on October 9, 2020 for the product Drug. The FDA reported the reason for recall as mislabeling of sus (n-a-c sustain 600 mg 100 tab) with n-a-c n-acetyl-l-cysteine 500 mg, 100 cap.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0302-2021

Reason for Recall
Mislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.
Initiated
10-09-2020
Reported
11-04-2020
Quantity
533 units

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
N-A-C (N-Acetyl-L-Cysteine, 500 mg, 100 capsules; Veggie Caps, white HDPE bottle with RED label Product # 107002 UPC: 790011070023

Batch or Lot Expiration Information

Lot# Lot 65323G20; Expiration: 7/22